Back
Stoke Therapeutics Stock Price Chart

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
4
STOK
Stoke Therapeutics
Last Price:
$7.04
Seasonality Move:
-2.4%
7 Day Trial
ALL ACCESS PASS
$
7

Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing buying pressure, which is a positive indicator for future bullish movement.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.24 | Buy |
20-day SMA: | 7.29 | Sell |
50-day SMA: | 8.69 | Sell |
200-day SMA: | 11.85 | Sell |
8-day EMA: | 6.43 | Buy |
20-day EMA: | 7.06 | Sell |
50-day EMA: | 8.28 | Sell |
200-day EMA: | 10.45 | Sell |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.71 | Sell |
Relative Strength Index (14 RSI): | 38.96 | Sell |
Chaikin Money Flow: | 839999 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Stoke Therapeutics Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 6.52 while STOK 8-day simple moving average is 6.24, which is a Buy signal.
-
The stock price of STOK is 6.52 while Stoke Therapeutics 20-day SMA is 7.29, which makes it a Sell.
-
Stoke Therapeutics 50-day simple moving average is 8.69 while STOK share price is 6.52, making it a Sell technically.
-
STOK stock price is 6.52 and Stoke Therapeutics 200-day simple moving average is 11.85, creating a Sell signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
4
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a SellThe current Stoke Therapeutics [STOK] share price is $6.52. The Score for STOK is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
352.6M
Price in USD:
6.52
Share Volume:
931.6K
Stoke Therapeutics 52-Week Range
52-Week High:
17.58
52-Week Low:
5.35
Sell
4
Stoke Therapeutics (STOK)
is a Sell
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?The Stoke Therapeutics stock price is 6.52 USD today.
-
Will STOK stock go up or go down?Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Stoke Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is overvalued.
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 6.52 while STOK 8-day exponential moving average is 6.43, which is a Buy signal.
-
The stock price of STOK is 6.52 while Stoke Therapeutics 20-day EMA is 7.06, which makes it a Sell.
-
Stoke Therapeutics 50-day exponential moving average is 8.28 while STOK share price is 6.52, making it a Sell technically.
-
STOK stock price is 6.52 and Stoke Therapeutics 200-day simple moving average is 10.45, creating a Sell signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and a decrease next year of $0.84 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
-
STOK Moving Average Covergence Divergence (MACD) indicator is -0.71, suggesting Stoke Therapeutics is a Sell
-
Stoke Therapeutics Relative Strength Index (RSI) is 38.96, which suggest Stoke Therapeutics is oversold
-
The Bollinger Bands (25) for Stoke Therapeutics is ( - ), which suggest Stoke Therapeutics is a Buy
-
The Bollinger Bands (100) for Stoke Therapeutics is ( - ), which suggest Stoke Therapeutics is a Buy
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.